Basit öğe kaydını göster

dc.contributor.authorGöktaş, Sonay
dc.contributor.authorAkın, Semiha
dc.contributor.authorKoşucu, Sibel Nargiz
dc.contributor.authorDoğan, Pınar
dc.date.accessioned2022-12-30T09:59:53Z
dc.date.available2022-12-30T09:59:53Z
dc.date.issued2022en_US
dc.identifier.citationGöktaş, S., Akın, S., Koşucu, S. N. ve Doğan, P. (2022). Frailty in older Turkish cancer patients undergoing post-surgical adjuvant chemotherapy. International Journal of Palliative Nursing, 28(12), 590-599. https://doi.org/10.12968/ijpn.2022.28.12.590en_US
dc.identifier.issn2052-286X
dc.identifier.issn1357-6321
dc.identifier.urihttps://doi.org/10.12968/ijpn.2022.28.12.590
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10215
dc.description.abstractBACKGROUND: Understanding the frailty levels of older patients undergoing surgery and chemotherapy will contribute to timely and reliable care practices and improve care outcomes. AIMS: To determine the frailty of cancer patients who received chemotherapy treatment after surgery. METHODS: This descriptive study included 192 Turkish patients aged over 60 years who received chemotherapy after surgery for cancer. Data were collected using a patient survey and the Edmonton Frailty Scale. RESULTS: The average age of the participants was 66.3±5.3 years. Around 40% (40.6%) of the sample were diagnosed with breast cancer. The Edmonton Frailty Scale score of the group was 6.6 (SD±3.7). A quarter of the sample (22.9%) were at risk of frailty. Frailty levels were higher in older individuals with gastrointestinal cancers and other cancer groups compared with patients with breast cancer (p<0.001); patients with additional chronic diseases other than cancer (p=0.004); and in those with a history of falling and hospitalisation in the past year (p<0.001). CONCLUSIONS: Older patients with gastrointestinal cancer, additional chronic disease and a history of falling and hospitalisation within the past year should be evaluated closely for frailty before and during chemotherapy. It is crucial to consider the patient's vulnerability when making care and treatment decisions for older patients with cancer. Understanding the frailty levels of older patients who undergo surgery and receive chemotherapy can help health professionals to decide on timely and reliable care practices and improve care outcomes.en_US
dc.language.isoengen_US
dc.publisherNLM (Medline)en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCanceren_US
dc.subjectChemotherapyen_US
dc.subjectFrailtyen_US
dc.subjectOlder Peopleen_US
dc.subjectPost-Surgeryen_US
dc.titleFrailty in older Turkish cancer patients undergoing post-surgical adjuvant chemotherapyen_US
dc.typearticleen_US
dc.relation.ispartofInternational Journal of Palliative Nursingen_US
dc.departmentİstanbul Medipol Üniversitesi, Sağlık Bilimleri Fakültesi, Hemşirelik Bölümüen_US
dc.authorid0000-0002-3566-7070en_US
dc.identifier.volume28en_US
dc.identifier.issue12en_US
dc.identifier.startpage590en_US
dc.identifier.endpage599en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.12968/ijpn.2022.28.12.590en_US
dc.institutionauthorDoğan, Pınar
dc.identifier.wos000899354400006en_US
dc.identifier.scopus2-s2.0-85144215573en_US
dc.identifier.pmid36520101en_US
dc.identifier.scopusqualityQ2en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster